Jeffrey V. Poulton
EVP, Chief Financial Officer at Alnylam Pharmaceuticals · 48 reported transactions in 1 company · latest trade Feb 13, 2026
Their trades
Sold | Feb 13, 2026 | Feb 13, 2026 close $314.40 → Oct 26, 2026 close $227.66. S&P 500 +12.3% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. |
$695.2K
Feb 13, 2026 close $314.40 → Oct 26, 2026 close $227.66. S&P 500 +12.3% over the same days.
$10.2K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$12.8K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$9.4K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$2.2K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$13.4K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$27K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$62.7K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.